0001447362-20-000175.txt : 20200814 0001447362-20-000175.hdr.sgml : 20200814 20200814160957 ACCESSION NUMBER: 0001447362-20-000175 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200812 FILED AS OF DATE: 20200814 DATE AS OF CHANGE: 20200814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MAETZOLD DEREK J CENTRAL INDEX KEY: 0001239501 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38984 FILM NUMBER: 201105141 MAIL ADDRESS: STREET 1: 820 S. FRIENDSWOOD DRIVE STREET 2: SUITE 201 CITY: FRIENDSWOOD STATE: TX ZIP: 77546 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CASTLE BIOSCIENCES INC CENTRAL INDEX KEY: 0001447362 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770701774 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 820 S FRIENDSWOOD DRIVE STREET 2: SUITE 201 CITY: FRIENDSWOOD STATE: TX ZIP: 77546 BUSINESS PHONE: 866-788-9007 MAIL ADDRESS: STREET 1: 820 S FRIENDSWOOD DRIVE STREET 2: SUITE 201 CITY: FRIENDSWOOD STATE: TX ZIP: 77546 4 1 wf-form4_159743570029800.xml FORM 4 X0306 4 2020-08-12 0 0001447362 CASTLE BIOSCIENCES INC CSTL 0001239501 MAETZOLD DEREK J C/O CASTLE BIOSCIENCES, INC. 820 S. FRIENDSWOOD DRIVE, SUITE 201 FRIENDSWOOD TX 77546 1 1 0 0 Pres. & Chief Exec. Officer Common Stock 2020-08-12 4 S 0 800 40.297 D 1563048 D Common Stock 2020-08-12 4 S 0 4200 41.903 D 1558848 D Common Stock 2020-08-13 4 S 0 7300 40.973 D 1551548 D Common Stock 2020-08-13 4 S 0 200 41.70 D 1551348 D Common Stock 2020-08-13 4 S 0 1000 40.909 D 1550348 D Common Stock 159329 I By trust These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 2, 2020. This transaction was executed in multiple trades at prices ranging from $39.940 to $40.765, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $41.520 to $42.240, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 18, 2020. This transaction was executed in multiple trades at prices ranging from $40.670 to $41.635, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $40.690 to $41.110, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Held by the DJM Grantor Retained Annuity Trust No. 1, or the Maetzold Trust. The Reporting Person is a trustee of the Maetzold Trust. /s/ Greg Acosta, Attorney-in-fact 2020-08-14